Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632
This examiner grants 44% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16985090 | Artificial Target Cells for in-vitro CAR Cytotoxicity and ADCC validation | Non-Final OA | ImmunityBio, Inc. |
| 17769712 | USE OF MOG FOR PRIMING A TREATMENT FOR GLIOBLASTOMA | Non-Final OA | The Regents of the University of California |
| 17025836 | GENERATION OF HUMAN iPS CELLS BY A SYNTHETIC SELF-REPLICATIVE RNA | Final Rejection | The Regents of the University of California |
| 18171862 | METHOD FOR PRODUCING THREE-DIMENSIONAL CELL STRUCTURE, AND THREE-DIMENSIONAL CELL STRUCTURE | Final Rejection | TOPPAN Inc. |
| 18012064 | PROGRAMMABLE ORGANOIDS AND METHODS OF PRODUCING THE SAME VIA ORTHOGONAL DIFFERENTIATION AND BIOPRINTING | Final Rejection | President and Fellows of Harvard College |
| 18659959 | NEUROPROTECTION GENE THERAPY | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17780170 | IMAGING INDIVIDUAL HIPPOCAMPAL SEIZURES AND THE LONG-TERM IMPACT OF REPEATED SEIZURES | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17920069 | NON-HUMAN ANIMALS HAVING A HUMANIZED CXCL13 GENE | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 17288628 | SYSTEMS AND BREEDING METHODS FOR PEST CONTROL | Final Rejection | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 18502136 | VARIANTS OF CAS12A NUCLEASES AND METHODS OF MAKING AND USE THEREOF | Final Rejection | Pairwise Plants Services, Inc. |
| 17995043 | METHOD FOR SEPARATING PITUITARY HORMONE-PRODUCING CELLS AND PROGENITOR CELLS THEREOF | Non-Final OA | National University Corporation Tokai National Higher Education and Research System |
| 18716858 | METHODS AND COMPOSITIONS FOR GENETICALLY MODIFYING HUMAN GUT MICROBES | Non-Final OA | Cornell University |
| 17588038 | IN VIVO GUIDE RNA LIBRARIES AND METHODS OF MAKING THE SAME | Non-Final OA | Whitehead Institute for Biomedical Research |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy